SigTuple
SigTuple: Business Model Canvas
The nine-block Business Model Canvas, filled in only where a public source states it — empty blocks mean we haven't found a citable fact yet, not that the answer is zero.
Value Propositions
AI, robotics, microfluidics and high-resolution microscopy combined to automate microscopic analysis of biological samples.
sourceBrowser-based review lets pathologists work from anywhere, addressing India's shortage of on-site pathologists.
sourceAI100 is FDA- and CE-cleared; positioned as the world's only automated AI-powered multi-purpose digital cell morphology analyser for both peripheral blood smear and urine sediment.
sourceCustomer testimonial from HCG's Executive Chairman on adopting AI100 across the hospital chain's Hematopathology labs.
sourceCustomer Segments
Served via the AS76 digital cell morphology analyser for peripheral blood smear.
sourceServed via the AI100 multi-purpose digital microscope for blood and urine analysis.
sourceHealthCare Global Enterprises Ltd (HCG) deployed AI100 across its Hematopathology labs network-wide.
sourceKrsnaa Diagnostics tied up with SigTuple to digitise its pathology lab network, starting with Punjab, Himachal Pradesh and Maharashtra.
sourceSigVet is a multi-test, AI-powered point-of-care platform for veterinary clinics.
sourceCustomer Relationships
Personalised walkthroughs focused on the customer's specific use case and workflow, with clinical and product specialists available for Q&A.
sourceChannels
Prospective lab customers book a live, personalised online demonstration with a product specialist.
sourceHORIBA and its affiliates distribute AI100 across the Indian subcontinent.
sourceOnboarded as a medical device distributor for sales and service in India, alongside HORIBA Medical.
sourceLocal distributor for SigTuple's expansion into the Indonesian market.
sourceKey Activities
Key Resources
27 granted patents in the US and India, per SigTuple's own disclosure — one of the more robust IP portfolios among Indian medtech startups.
sourceOver a decade of R&D and 30+ publications underpin the AI/robotics/microfluidics stack.
sourceKey Partnerships
Partnership to accelerate adoption of AI100 across the Indian subcontinent, with HORIBA distributing the device.
sourceHealthCare Global Enterprises Ltd equipped its Hematopathology labs network-wide with AI100.
sourceKrsnaa tied up with SigTuple to digitise its pathology lab network via a tele-pathology reporting centre in Pune.
sourceAI100 deployed across major Indian laboratory and hospital chains including Manipal and SRL, alongside HCG.
sourceThyrocare deployed AI100 to automate its manual microscopy process, with pilot installations at its Lucknow, Nagpur and Ranchi labs.
sourceRevenue Streams
Cost Structure
FAQs on SigTuple
What is SigTuple's business model?
SigTuple's core value proposition centers on Automates manual microscopy end-to-end, Remote pathologist review at scale, Regulatory-cleared, clinical-grade accuracy, Precision and efficiency gains for hospital labs.